Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational redesign and directed evolution of a lanthanide-dependent photoredox enzyme for enantioselective diol cleavage.

Chemical science·2026
Same author

Metronidazole and ether derivatives target Helicobacter pylori via simultaneous stress induction and inhibition.

Nature microbiology·2026
Same author

Distal peptide elongation by a protease-like ligase and two distinct carrier proteins.

Chem·2026
Same author

Structural Revision of the C<sub>16</sub> Sesquiterpene Hegelenether and the Mechanism of C6-Methylation in Terpene Biosynthesis.

Angewandte Chemie (International ed. in English)·2026
Same author

Structure-Based Design of Pan-Selective Peptide Epoxyketones for the Three Human Immunoproteasome Active Sites.

Journal of medicinal chemistry·2026
Same author

Structural Mimics of Hydrocarbon Intermediates Reveal Counterclockwise Cyclization Pathways in the Sesquiterpene Synthases TmS and NcECS.

Journal of the American Chemical Society·2025

Related Experiment Video

Updated: May 14, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Applied techniques for mining natural proteasome inhibitors.

Martin L Stein1, Michael Groll

  • 1Center for Integrated Protein Science at the Department Chemie, Lehrstuhl für Biochemie, Technische Unversität München, Lichtenbergstraße 4, 85748 Garching, Germany.

Biochimica Et Biophysica Acta
|January 31, 2013
PubMed
Summary

Natural products offer potent strategies for developing new drugs targeting the ubiquitin-proteasome-system (UPS). This review explores methods for discovering novel UPS inhibitors, focusing on syrbactins for enhanced therapeutic applications.

Keywords:
Drug developmentHigh-throughput-screeningMethodologyNatural productProteasome

More Related Videos

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

Related Experiment Videos

Last Updated: May 14, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
10:50

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics

Published on: July 16, 2018

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • The ubiquitin-proteasome-system (UPS) is crucial for protein homeostasis and a key target for cancer and immunosuppressive therapies.
  • Natural products derived from bacteria are highly potent and selective modulators of host UPS components, serving as ideal drug leads.
  • Existing proteasome inhibitors like bortezomib and carfilzomib have limitations, driving the need for novel compounds with improved efficacy and safety profiles.

Purpose of the Study:

  • To review techniques for discovering natural product-based inhibitors of the 20S proteasome.
  • To highlight the potential of previously unexploited natural compounds, such as syrbactins, as proteasome inhibitors.
  • To illustrate a methodology for identifying and characterizing novel UPS inhibitors.

Main Methods:

  • Literature review of natural product discovery techniques for UPS inhibitors.
  • Analysis of existing successful natural product-derived drugs targeting the proteasome.
  • Case study on syrbactins, detailing their discovery and biological functions.

Main Results:

  • Natural products provide a rich source for developing potent and selective UPS inhibitors.
  • Sybactins represent a promising, yet underexplored, class of proteasome inhibitors.
  • A recently published methodology has been successfully applied to identify and characterize syrbactins.

Conclusions:

  • Novel natural product inhibitors targeting the ubiquitin-proteasome-system hold significant therapeutic potential.
  • Further research into compounds like syrbactins could lead to improved treatments for various diseases.
  • Developing new UPS inhibitors is essential to overcome limitations of current therapies.